Michel Eichelbaum
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Antibiotics Pharmacokinetics and Efficacy 3
- Plant-based Medicinal Research 2
-
- Drug Solubulity and Delivery Systems 2
- Co-authors
- Martin F. FrommJoachim E. FischerElke SchäffelerSiegfried DrescherHeiko van der KuipMonika HitzlMatthias SchwabChristiane Pauli‐Magnus
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Biochemical Pharmacology (2 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Archives of Toxicology (1 paper)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Michel Eichelbaum
14 papers receiving 905 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 349
- Oncology 560
- Pediatrics, Perinatology and Child Health 388
- Transplantation 25
- Psychiatry and Mental health 97
Countries citing papers authored by Michel Eichelbaum
This map shows the geographic impact of Michel Eichelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Eichelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Eichelbaum more than expected).
Fields of papers citing papers by Michel Eichelbaum
This network shows the impact of papers produced by Michel Eichelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Eichelbaum. The network helps show where Michel Eichelbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Michel Eichelbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 1 | |
| 2 | 2001 | 318 | |
| 3 | 2001 | 119 | |
| 4 | 2001 | 44 | |
| 5 | 2000 | 172 | |
| 6 | 1999 | 25 | |
| 7 | 1999 | 49 | |
| 8 | Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations. | 1999 | 43 |
| 9 | 1996 | 3 | |
| 10 | 1994 | 34 | |
| 11 | 1988 | 59 | |
| 12 | 1988 | 6 | |
| 13 | 1987 | 13 | |
| 14 | 1984 | 45 |
About Michel Eichelbaum
Michel Eichelbaum is a scholar working on Pharmacology, Pharmaceutical Science, Ophthalmology, Oncology and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 931 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Drug Solubulity and Delivery Systems (2 papers), Plant-based Medicinal Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and Drug-Induced Ocular Toxicity (2 papers). The work is most often cited by research in Pharmacology (349 citations), Oncology (560 citations), Pediatrics, Perinatology and Child Health (388 citations), Transplantation (25 citations) and Psychiatry and Mental health (97 citations). Michel Eichelbaum has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Martin F. Fromm, Joachim E. Fischer, Elke Schäffeler, Siegfried Drescher, Heiko van der Kuip, Monika Hitzl, Matthias Schwab, Christiane Pauli‐Magnus, Thomas Mettang and Klaus Eckhardt. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology, Naunyn-Schmiedeberg s Archives of Pharmacology, Clinical Pharmacology & Therapeutics and Archives of Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.